Therapy (HBV)
Emtricitabine Shows Marked Anti-Hepatitis B Activity in Dose-Selection Trial
Published in Hepatitis Weekly, December 4th, 2000
The data were presented at the 51st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). Coviracil is a nucleoside analogue that Triangle is also developing for the treatment of HIV infection.
The 24-week, double-blind, randomized trial compared the anti-HBV activity of Coviracil in doses of 25 mg once daily (qd), 100 mg qd, and 200 mg qd. Ninety eight patients with chronic HBV infection participated...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2000-12-04)
More Articles from Hepatitis Weekly
- Vertical Transmission
Hepatitis C Infection of Immune Cells in Mothers Predicts Transfer to Newborns - Bone Marrow Transplantation
Incidence of Liver Disease Following Allogeneic Transplant Suggests Need for Follow-Up - Disease Association
Fatigue Common in Hepatitis C Patients, Especially Women - Education
Key Factors for Hepatitis C Virus Training Programs Outlined by Foundation - Interferon Therapy
Increased Cytokine Level Explains Treatment Failure in Viral Hepatitis - Vaccine Development
Data Presented on Hepatitis E Vaccine Tested in Rhesus Monkeys - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
